Curative Biotechnology (CUBT) Short Interest Ratio & Short Volume

Short interest is the volume of Curative Biotechnology shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 7,000 shares of CUBT short. Learn More on Curative Biotechnology's current short interest.

Curative Biotechnology saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 7,000 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Curative Biotechnology: Acrivon Therapeutics, Inc. (3.14%), CalciMedica Inc. (0.78%), MariMed Inc. (0.01%), Pluri Inc. (0.77%), Jasper Therapeutics, Inc. (10.25%), Zomedica Corp. (0.04%), Ovid Therapeutics (2.71%), Shattuck Labs, Inc. (1.06%), ALX Oncology Holdings Inc. (12.18%), Charlie's Holdings, Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

Short selling CUBT is an investing strategy that aims to generate trading profit from Curative Biotechnology as its price is falling. CUBT shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Curative Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CUBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUBT, twice per month. The most recent reporting period available is July, 15 2025.